InvestorsHub Logo
Followers 271
Posts 15407
Boards Moderated 1
Alias Born 03/28/2013

Re: tradeherpete post# 78541

Sunday, 10/23/2016 3:10:31 PM

Sunday, October 23, 2016 3:10:31 PM

Post# of 457461
I am not the person to ask, I apologize

But, I did email the FDA about a similar subject

Here is my (edited) correspondence

Sent: June 12, 2016
"Thank you for Form 3926 - Individual Patient Expanded Access Investigation New Drug Application - Anavex 2-73

How can i best spread this information to doctors?

Much love and respect (edits)"

Received: June 20, 2016
Good morning, (edit)
Thanks so much for you nice note. I can’t say we get very many.
We’ve been working to try and make single patient expanded access easier and more flexible for physicians unfamiliar with regulatory pathways and paperwork.
Any effort to help make physicians more aware of the new form 3926 and accompanying guidance document on filing for single patient access is much appreciated!

Best,
Richard


Richard Klein
Director, Patient Liaison Program
Office of Health and Constituent Affairs
Food and Drug Administration


________________________________________________________________________________________________________________________________________

FDA Office of Media Affairs
301-796-4669"

Sent: June 21, 2016
"Thank you for the kind response
I will spread the word!
Would Anavex 2-73 be available through the use of said form?

Much love and respect, (edit)"

(I have yet to receive a response)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News